Observing oxygenation practices during fiberoptic bronchoscopy
Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy: the Oxy-FOB STUDY
This study looks at how doctors provide oxygen and breathing support to adults during fiberoptic bronchoscopy to better understand current practices.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Magna Graecia Academic / other |
| Locations | 1 site (Catanzaro) |
| Trial ID | NCT05681962 on ClinicalTrials.gov |
What this trial studies
This observational study aims to describe the current practices of oxygenation and ventilation support in patients undergoing fiberoptic bronchoscopy (FOB). It will stratify data based on patients' baseline respiratory conditions, co-morbidities, types of procedures, and hospital settings. All adult patients requiring any form of FOB will be enrolled, with no specific exclusion criteria. Data collected will include baseline patient information and details about the type of FOB procedure performed.
Who should consider this trial
Good fit: Ideal candidates include adult patients requiring fiberoptic bronchoscopy, regardless of their respiratory condition or hospital setting.
Not a fit: Patients who do not require fiberoptic bronchoscopy or are not adults may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help standardize oxygenation practices during bronchoscopy, potentially improving patient outcomes.
How similar studies have performed: While there is variability in practices, this study aims to fill a gap in understanding, suggesting it may be novel or underexplored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Need for any procedure with flexible FOB * Either outpatients in dedicated ambulatories, and admitted to any hospital ward or Intensive Care Unit (ICU) Exclusion Criteria: * None
Where this trial is running
Catanzaro
- AOU Mater Domini — Catanzaro, Italy (Recruiting)
Study contacts
- Principal investigator: Federico Longhini, MD — Magna Graecia University
- Study coordinator: Federico Longhini, MD
- Email: longhini.federico@gmail.com
- Phone: +393475395967
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.